|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 249/12 | |
| C07D 401/04 | |||
| C07D 405/04 | |||
| C07D 403/04 | |||
| A61K 31/4196 | |||
| A61P 35/00 |
| (11) | Number of the document | 2295416 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10075465.4 |
| Date of filing the European patent application | 2005-11-17 | |
| (97) | Date of publication of the European application | 2011-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 628979 P | 2004-11-18 | US | |
| 709358 P | 2005-08-18 | US | |
| 725044 P | 2005-10-06 | US |
| (72) |
Ying, Weiwen, US
James, David, US
Zhang, Shijie, US
Przewloka, Teresa, US
Chae, Junghyun, KR
Chimmanamada, Dinesh U, US
Lee, Chi-Wan, US
Kostik, Elena, US
Ng, Howard P., US
Foley, Kevin, US
Du, Zhenjian, US
Barsoum, James, US
|
| (73) |
Synta Pharmaceuticals Corp.,
45 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | Triazole compounds that modulate HSP90 activity |
| Triazole compounds that modulate HSP90 activity |